|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Grant income | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Loss on early termination of vendor agreement | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Interest income | |||||
| Other income | |||||
| Loss from operations before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net loss from continuing operations | |||||
| Loss from discontinued operations | |||||
| Gain on disposal of discontinued operations, net of $63,000 in tax | |||||
| Income (loss) from discontinued operations | |||||
| Net loss | |||||
| Net earnings (loss) per share: | |||||
| Loss from continuing operations, basic (in dollars per share) | |||||
| Income from discontinued operations, basic (in dollars per share) | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...